Enliven Therapeutics Up Over 58%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk

Dow Jones

Jan 08

Enliven Therapeutics, Inc. $(ELVN)$ is currently at $24.52, up $9.05 or 58.5%

--Would be highest close since Dec. 6, 2024, when it closed at $25.42

--On pace for largest percent increase since Sept. 7, 2022, when it rose 71.79%

--Currently up two consecutive days; up 61.96% over this period

--Best two day stretch since the two days ending Sept. 8, 2022, when it rose 82.91%

--Up 59.22% month-to-date

--Up 59.22% year-to-date

--Down 88.83% from its all-time closing high of $219.48 on June 11, 2020

--Up 1.53% from 52 weeks ago (Jan. 8, 2025), when it closed at $24.15

--Would be a new 52-week closing high

--Up 64.45% from its 52-week closing low of $14.91 on April 10, 2025

--Traded as high as $25.59; highest intraday level since Dec. 9, 2024, when it hit $25.67

--Up 65.42% at today's intraday high; largest intraday percent increase since Sept. 7, 2022, when it rose as much as 74.36%

All data as of 10:46:44 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 08, 2026 10:48 ET (15:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2601952733"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601952733\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601952733?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 23:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601952733","market":"fut","top_or_hot":-1,"title":"Enliven Therapeutics Up Over 58%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Enliven <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. <a href=\"https://laohu8.com/S/ELVN\">$(ELVN)$</a> is currently at $24.52, up $9.05 or 58.5% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since Dec. 6, 2024, when it closed at $25.42 \n</p>\n<p>\n     --On pace for largest percent increase since Sept. 7, 2022, when it rose 71.79% \n</p>\n<p>\n     --Currently up two consecutive days; up 61.96% over this period \n</p>\n<p>\n     --Best two day stretch since the two days ending Sept. 8, 2022, when it rose 82.91% \n</p>\n<p>\n     --Up 59.22% month-to-date \n</p>\n<p>\n     --Up 59.22% year-to-date \n</p>\n<p>\n     --Down 88.83% from its all-time closing high of $219.48 on June 11, 2020 \n</p>\n<p>\n     --Up 1.53% from 52 weeks ago (Jan. 8, 2025), when it closed at $24.15 \n</p>\n<p>\n     --Would be a new 52-week closing high \n</p>\n<p>\n     --Up 64.45% from its 52-week closing low of $14.91 on April 10, 2025 \n</p>\n<p>\n     --Traded as high as $25.59; highest intraday level since Dec. 9, 2024, when it hit $25.67 \n</p>\n<p>\n     --Up 65.42% at today's intraday high; largest intraday percent increase since Sept. 7, 2022, when it rose as much as 74.36% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 10:46:44 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2026 10:48 ET (15:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Enliven Therapeutics Up Over 58%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnliven Therapeutics Up Over 58%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-08 23:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Enliven <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc. <a href=\"https://laohu8.com/S/ELVN\">$(ELVN)$</a> is currently at $24.52, up $9.05 or 58.5% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since Dec. 6, 2024, when it closed at $25.42 \n</p>\n<p>\n     --On pace for largest percent increase since Sept. 7, 2022, when it rose 71.79% \n</p>\n<p>\n     --Currently up two consecutive days; up 61.96% over this period \n</p>\n<p>\n     --Best two day stretch since the two days ending Sept. 8, 2022, when it rose 82.91% \n</p>\n<p>\n     --Up 59.22% month-to-date \n</p>\n<p>\n     --Up 59.22% year-to-date \n</p>\n<p>\n     --Down 88.83% from its all-time closing high of $219.48 on June 11, 2020 \n</p>\n<p>\n     --Up 1.53% from 52 weeks ago (Jan. 8, 2025), when it closed at $24.15 \n</p>\n<p>\n     --Would be a new 52-week closing high \n</p>\n<p>\n     --Up 64.45% from its 52-week closing low of $14.91 on April 10, 2025 \n</p>\n<p>\n     --Traded as high as $25.59; highest intraday level since Dec. 9, 2024, when it hit $25.67 \n</p>\n<p>\n     --Up 65.42% at today's intraday high; largest intraday percent increase since Sept. 7, 2022, when it rose as much as 74.36% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 10:46:44 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2026 10:48 ET (15:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2601952733","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601952733","pubTimestamp":1767887280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Enliven Therapeutics, Inc.  is currently at $24.52, up $9.05 or 58.5%. --Would be highest close since Dec. 6, 2024, when it closed at $25.42. --On pace for largest percent increase since Sept. 7, 2022, when it rose 71.79%. --Currently up two consecutive days; up 61.96% over this period. --Down 88.83% from its all-time closing high of $219.48 on June 11, 2020. --Up 1.53% from 52 weeks ago , when it closed at $24.15. --Up 64.45% from its 52-week closing low of $14.91 on April 10, 2025. --Traded as high as $25.59; highest intraday level since Dec. 9, 2024, when it hit $25.67. --Up 65.42% at today's intraday high; largest intraday percent increase since Sept. 7, 2022, when it rose as much as 74.36%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","BK4007":"制药","LENZ":"Therapeutics","ELVN":"Enliven Treateutics"},"translate_title":"Enliven Therapeutics上涨超过58%，有望创2022年9月以来最大百分比涨幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"ELVN":1},"content_text":"Enliven Therapeutics, Inc. $(ELVN)$ is currently at $24.52, up $9.05 or 58.5% \n\n\n \n\n\n     --Would be highest close since Dec. 6, 2024, when it closed at $25.42 \n\n\n     --On pace for largest percent increase since Sept. 7, 2022, when it rose 71.79% \n\n\n     --Currently up two consecutive days; up 61.96% over this period \n\n\n     --Best two day stretch since the two days ending Sept. 8, 2022, when it rose 82.91% \n\n\n     --Up 59.22% month-to-date \n\n\n     --Up 59.22% year-to-date \n\n\n     --Down 88.83% from its all-time closing high of $219.48 on June 11, 2020 \n\n\n     --Up 1.53% from 52 weeks ago (Jan. 8, 2025), when it closed at $24.15 \n\n\n     --Would be a new 52-week closing high \n\n\n     --Up 64.45% from its 52-week closing low of $14.91 on April 10, 2025 \n\n\n     --Traded as high as $25.59; highest intraday level since Dec. 9, 2024, when it hit $25.67 \n\n\n     --Up 65.42% at today's intraday high; largest intraday percent increase since Sept. 7, 2022, when it rose as much as 74.36% \n\n\n \n\n\n     All data as of 10:46:44 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 10:48 ET (15:48 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}